Recommended Dose: 200 mg Vaginal Micronized Progesterone Daily
For luteal phase support in reproductive-age women, vaginal micronized progesterone 200 mg daily for 12-14 days per 28-day cycle is the recommended dose for endometrial protection and optimal uterine lining development. 1
Dosing Regimen
The most recent 2021 guidelines provide clear dosing protocols for luteal phase progesterone supplementation 1:
- Standard dose: 200 mg vaginal micronized progesterone (MP) daily
- Timing: Administered for 12-14 days every 28 days in sequential regimens
- Alternative oral dosing: 200 mg oral MP for 12-14 days per month (though vaginal route is preferred)
Evidence Supporting This Dose
The 2011 AACE guidelines confirm that micronized progesterone at 100 mg daily or 200 mg for 10-12 days per month provides adequate endometrial protection 2. However, the more recent 2021 Blood Reviews guideline specifically recommends the 200 mg dose for 12-14 days as the standard approach 1.
Micronized progesterone is the first-choice progestogen due to its superior safety profile, with lower risks of cardiovascular disease and venous thromboembolism compared to synthetic progestins 1.
Route of Administration Considerations
Vaginal administration offers several advantages:
- Fewer systemic side effects compared to oral administration 2
- Direct uterine delivery with adequate endometrial management 2
- Proven effectiveness in maintaining luteal phase endometrial integrity 2
Research demonstrates that vaginal progesterone 200-400 mg every 12 hours rapidly achieves and maintains physiological serum progesterone levels appropriate for the luteal phase 3. Studies show vaginal progesterone supplementation increases endometrial thickness, which may enhance receptivity for implantation 4.
Clinical Context
For continuous (non-cyclic) regimens when withdrawal bleeding is to be avoided, continuous combined formulations require lower daily doses. However, for sequential luteal phase support specifically—which is what your question addresses—200 mg daily for 12-14 days per cycle is the established dose 1.
Important Caveats
Peanut allergy: Most micronized progesterone capsules contain peanut oil and are contraindicated in patients with peanut allergies 5. Vaginal gel formulations do not contain peanut oil and can be used as alternatives.
Timing matters: The progesterone should be administered during the luteal phase (after ovulation or embryo transfer), not throughout the entire cycle.
Drowsiness: Some women experience significant drowsiness or dizziness with progesterone; bedtime administration is recommended 5.